Page last updated: 2024-08-17

apomorphine and Psychotic Disorders

apomorphine has been researched along with Psychotic Disorders in 45 studies

Research

Studies (45)

Timeframe	Studies, this research(%)	All Research%
pre-1990	20 (44.44)	18.7374
1990's	4 (8.89)	18.2507
2000's	8 (17.78)	29.6817
2010's	12 (26.67)	24.3611
2020's	1 (2.22)	2.80

Authors

Authors	Studies
Abdulrahim, HA; Aderibigbe, AO; Bakre, AG; Ben-Azu, B; Ezurike, PU; Isibor, H; Omeiza, NA; Sowunmi, AA	1
B, NK; Badami, S; Dhadde, SB; Durg, S; Thippeswamy, BS; Vandal, R; Veerapur, VP	1
Adjei, S; Amoateng, P; Bekoe, EO; Karikari, TK; Kombian, SB; Kukuia, KKE; Osei-Safo, D	1
Gogos, A; Sbisa, A; van den Buuse, M	1
Dixit, TS; Elased, KM; Lucot, JB; Sharma, AN	1
Hacksell, U; Hubbard, D; McFarland, K	1
Abdulla, A; Kaklotar, D; Muthu, MS; Pandey, BL; Rajesh, CV; Sahu, AK; Singh, S	1
Azar, MR; Geyer, MA; Gold, L; Marston, HM; Martin, FD; Meltzer, LT; Moore, CL; Serpa, KA; Shahid, M; Wong, EH; Young, JW	1
Andreatini, R; Chioca, LR; Correia, D; Pereira, M; Pizzolatti, MG; Santos, AR; Siba, IP; Vital, MA	1
Schnitzler, A; Südmeyer, M; Wojtecki, L	1
Andreeva, LA; Batishcheva, EIu; Kost, NV; Meshavkin, VK; Miasoedov, NF; Sokolov, OIu	1
Bilge, U; Erol, K	1
Dabole, B; Dawe, A; De Waard, M; Dimo, T; Djomeni Dzeufiet, PD; Ngo Bum, E; Okomolo Moto, FC; Sidiki, N; Sotoing Taïwe, G; Talla, E; Temkou Ngoupaye, G	1
Kulisevsky, J; Martí, MJ	1
Brown, N; Campbell, IC; Checkley, SA; Davies, T; Kumar, C; Marks, MN; McIvor, RJ; Papadopoulos, A; Wieck, A	1
Andersen, MB; Bymaster, F; Fink-Jensen, A; Gerlach, J; Lundbaek, JA; Peacock, L; Werge, T	1
LANG, A; MESTRALLET, A	1
NIXON, JW; QUINN, JT	1
NAHUNEK, K	1
Marona-Lewicka, D; Nichols, DE; Thisted, RA	1
Cañete, T; Fernández-Teruel, A; Giménez-Llort, L; Guitart-Masip, M; Tobeña, A	1
Brotchie, JM; Fox, SH; Gomez-Ramirez, J; Johnston, TH; Pires, D; Visanji, NP; Voon, V	1
Garver, DL; Hirschowitz, J; Hitzemann, R; Mavroidis, ML; Zemlan, F	1
Garver, DL; Hirschowitz, J; Zemlan, FP	2
Garver, D; Hirschowitz, J; Hitzemann, B; Hitzemann, R	1
Lewine, R; Meltzer, HY; Perline, R	1
Brockington, IF; Jones, SR; Lynch, S; Meakin, CJ	1
Campbell, I; Checkley, S; Hirst, D; Kumar, R; Marks, M; Wieck, A	1
Alvir, JM; Ashtari, M; Bogerts, B; Cooper, T; Degreef, G; Jody, D; Levy, DL; Lieberman, JA; Mayerhoff, DI	1
Bassi, A; Cicardi, MC; Loberti, M; Pierantozzi, M; Semprini, R; Stanzione, P; Traversa, R	1
Allikmets, L; Matto, V; Pruus, K; Rudissaar, R; Skrebuhhova-Malmros, T	1
Tamminga, CA	1
Costentin, J	1
Chowdhury, BK; Iriah, J; Ogbeide, ON; Orkor, D; Sokomba, E; Wambebe, C	1
Garver, DL; Hirschowitz, J; Sautter, F; Zemlan, FP	1
Fleischmann, RL; Garver, DL; Hirschowitz, J; Hitzemann, RJ; Zemlan, FP	1
Crow, TJ; Ferrier, IN; Johnstone, EC	1
Davidson, M; Davis, BM; Davis, KL; Horvath, TB; Kendler, KS; Mohs, RC	1
Angrist, B; Gershon, S	1
Dresse, A; Janssen, PA; Lenaerts, FM; Niemegeers, CJ; Pinchard, A; Schaper, WK; Schellekens, KH; van Nueten, JM; Verbruggen, FJ	1
Arnold, OH; Collard, J; Deniker, P; Ginestet, D; Hippius, H; Itil, TM; Labhardt, F; Leeds, AA; Montanini, R; Morozov, G; Simon, P; Villeneuve, A	1
Boissier, JR; Janssen, PA; Julou, L; Loew, DM; Moller Nielsen, I; Munkvad, I; Randrup, A; Stille, G; Tedeschi, DH; Van Rossum, JM	1
Randrup, A	1

Reviews

6 review(s) available for apomorphine and Psychotic Disorders

Article	Year
[Current treatment strategies for Parkinson's disease]. Fortschritte der Neurologie-Psychiatrie, 2011, Volume: 79, Issue:12 Topics: Aged; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Apomorphine; Critical Care; Deep Brain Stimulation; Dementia; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Europe; Female; Humans; Infusion Pumps, Implantable; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Tremor	2011
[Candidate patient for treatment with continuous apomorphine infusion]. Revista de neurologia, 2012, Volume: 55 Suppl 1 Topics: Aged; Antiparkinson Agents; Apomorphine; Clinical Trials as Topic; Cognition Disorders; Contraindications; Depression; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Hallucinations; Humans; Infusions, Intravenous; Middle Aged; Parkinson Disease; Patient Selection; Psychoses, Substance-Induced; Psychotic Disorders	2012
Biological studies of DSM-III psychotic disorders. I. Platelet measures and apomorphine-induced growth hormone response. The Journal of nervous and mental disease, 1982, Volume: 170, Issue:12 Topics: Adult; Apomorphine; Blood; Blood Platelets; Female; Growth Hormone; Humans; Male; Manuals as Topic; Monoamine Oxidase; Psychotic Disorders; Schizophrenia; Serotonin	1982
Partial dopamine agonists in the treatment of psychosis. Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:3 Topics: Animals; Apomorphine; Autoreceptors; Brain; Dopamine Agonists; Humans; Piperidines; Psychotic Disorders; Receptors, Dopamine	2002
[Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation]. L'Encephale, 1979, Volume: 5, Issue:2 Topics: Acetylcholine; Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Behavior; Corpus Striatum; Dogs; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Hypothermia; Levodopa; Memory; Mice; Opioid-Related Disorders; Parkinson Disease; Psychotic Disorders; Rats; Receptors, Dopamine; Sleep; Stereotyped Behavior; Substantia Nigra; Synapses; Synaptic Transmission	1979
Dopamine and psychotic states: preliminary remarks. Advances in biochemical psychopharmacology, 1974, Volume: 12, Issue:0 Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Carbon Radioisotopes; Cats; Cocaine; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Humans; Methylphenidate; Pemoline; Phenmetrazine; Pimozide; Psychoses, Substance-Induced; Psychotic Disorders; Rats; Receptors, Cell Surface; Species Specificity; Stereotyped Behavior; Thioridazine; Tyrosine	1974

Trials

2 trial(s) available for apomorphine and Psychotic Disorders

Article	Year
Estrogen administration does not reduce the rate of recurrence of affective psychosis after childbirth. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:2 Topics: Administration, Cutaneous; Affective Disorders, Psychotic; Apomorphine; Bipolar Disorder; Depression, Postpartum; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogens; Female; Human Growth Hormone; Humans; Neurotransmitter Agents; Pregnancy; Prolactin; Psychotic Disorders; Puerperal Disorders; Receptors, Dopamine; Secondary Prevention; Treatment Outcome	2003
Dopamine and non-dopamine psychoses. Psychopharmacology, 1984, Volume: 84, Issue:1 Topics: Antipsychotic Agents; Apomorphine; Growth Hormone; Humans; Psychotic Disorders; Receptors, Dopamine; Time Factors	1984

Article

Year

Estrogen administration does not reduce the rate of recurrence of affective psychosis after childbirth.

The Journal of clinical psychiatry, 2003, Volume: 64, Issue:2

Topics: Administration, Cutaneous; Affective Disorders, Psychotic; Apomorphine; Bipolar Disorder; Depression, Postpartum; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogens; Female; Human Growth Hormone; Humans; Neurotransmitter Agents; Pregnancy; Prolactin; Psychotic Disorders; Puerperal Disorders; Receptors, Dopamine; Secondary Prevention; Treatment Outcome

2003

Dopamine and non-dopamine psychoses.

Psychopharmacology, 1984, Volume: 84, Issue:1

Topics: Antipsychotic Agents; Apomorphine; Growth Hormone; Humans; Psychotic Disorders; Receptors, Dopamine; Time Factors

1984

Other Studies

37 other study(ies) available for apomorphine and Psychotic Disorders

Article	Year
Pretreatment with Carpolobia lutea ethanol extract prevents schizophrenia-like behavior in mice models of psychosis. Journal of ethnopharmacology, 2022, Sep-15, Volume: 295 Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Ethanol; Ketamine; Male; Mice; Plant Extracts; Psychotic Disorders; Schizophrenia	2022
Antipsychotic activity of embelin isolated from Embelia ribes: A preliminary study. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 90 Topics: Animals; Antipsychotic Agents; Apomorphine; Benzoquinones; Brain; Embelia; Mice; Neurotransmitter Agents; Plant Extracts; Psychotic Disorders; Rats; Rats, Wistar	2017
Extract of Synedrella nodiflora (L) Gaertn exhibits antipsychotic properties in murine models of psychosis. BMC complementary and alternative medicine, 2017, Aug-07, Volume: 17, Issue:1 Topics: Animals; Antipsychotic Agents; Apomorphine; Asteraceae; Behavior, Animal; Catalepsy; Chlorpromazine; Disease Models, Animal; Haloperidol; Herb-Drug Interactions; Hypnotics and Sedatives; Mice, Inbred BALB C; Mice, Inbred ICR; Motor Activity; Phytotherapy; Plant Extracts; Psychotic Disorders	2017
The effect of estrogenic compounds on psychosis-like behaviour in female rats. PloS one, 2018, Volume: 13, Issue:3 Topics: Animals; Apomorphine; Dopamine Agonists; Estradiol; Estrogens; Female; Ovariectomy; Psychotic Disorders; Raloxifene Hydrochloride; Rats; Rats, Long-Evans; Receptors, Dopamine; Schizophrenia; Selective Estrogen Receptor Modulators; Tamoxifen	2018
Antipsychotic-like effect of GLP-1 agonist liraglutide but not DPP-IV inhibitor sitagliptin in mouse model for psychosis. Physiology & behavior, 2013, Apr-10, Volume: 114-115 Topics: Animals; Antipsychotic Agents; Apomorphine; Disease Models, Animal; Dopamine Agonists; Glucagon-Like Peptide 1; Liraglutide; Male; Mice; Psychotic Disorders; Pyrazines; Sitagliptin Phosphate; Statistics, Nonparametric; Triazoles	2013
Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios. Behavioural pharmacology, 2013, Volume: 24, Issue:7 Topics: Amphetamine; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Clozapine; Dopamine; Dose-Response Relationship, Drug; Male; Parkinsonian Disorders; Piperidines; Psychotic Disorders; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Urea	2013
Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management. Drug delivery, 2016, Volume: 23, Issue:1 Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Chemistry, Pharmaceutical; Drug Compounding; Drug Delivery Systems; Mice; Micelles; Paliperidone Palmitate; Particle Size; Polyethylene Glycols; Psychotic Disorders; Vitamin E	2016
Asenapine effects in animal models of psychosis and cognitive function. Psychopharmacology, 2009, Volume: 206, Issue:4 Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Attention; Benzodiazepines; Cognition; Dibenzocycloheptenes; Disease Models, Animal; Dose-Response Relationship, Drug; Heterocyclic Compounds, 4 or More Rings; Male; Olanzapine; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Risperidone	2009
Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Aug-15, Volume: 35, Issue:7 Topics: Animals; Antipsychotic Agents; Apomorphine; Arginine; Catalepsy; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Flavonoids; Indazoles; Male; Mice; Motor Activity; Nitric Oxide; Phytotherapy; Plant Leaves; Plant Preparations; Protein Kinase C; Psychotic Disorders; Rats; Rats, Wistar; Stereotyped Behavior; Syzygium; Tamoxifen	2011
[Neurotensin-like oligopeptides as potential antipsychotics: effect on dopamine system]. Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:10 Topics: Animals; Animals, Outbred Strains; Antipsychotic Agents; Apomorphine; Behavior, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Male; Mice; Neurotensin; Oligopeptides; Psychotic Disorders; Radioligand Assay; Rats; Receptors, Dopamine; Stereotyped Behavior; Sulpiride; Yawning	2011
Effects of sertraline on experimental mouse models of psychosis. Neurosciences (Riyadh, Saudi Arabia), 2012, Volume: 17, Issue:1 Topics: Animals; Antidepressive Agents; Apomorphine; Catalepsy; Dextroamphetamine; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Haloperidol; Mice; Motor Activity; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors	2012
Antipsychotic and sedative effects of the leaf extract of Crassocephalum bauchiense (Hutch.) Milne-Redh (Asteraceae) in rodents. Journal of ethnopharmacology, 2012, Aug-30, Volume: 143, Issue:1 Topics: Animals; Antipsychotic Agents; Apomorphine; Asteraceae; Behavior, Animal; Body Temperature; Brain; Catalepsy; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Flumazenil; GABA Agents; gamma-Aminobutyric Acid; Hypnotics and Sedatives; Male; Medicine, African Traditional; Mice; Mice, Inbred Strains; Motor Activity; Pentobarbital; Phytotherapy; Plant Extracts; Plant Leaves; Psychotic Disorders; Rats, Sprague-Dawley; Receptors, GABA-A; Sleep; Valproic Acid	2012
The muscarinic M1/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:6 Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Cebus; Male; Muscarinic Agonists; Psychotic Disorders; Pyridines; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Receptors, Muscarinic; Thiadiazoles	2003
[Indications, technics & results in apomorphine therapy of psychiatric alcoholism]. Journal de medecine de Lyon, 1959, Apr-05, Volume: 40, Issue:942 Topics: Alcoholism; Apomorphine; Humans; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders	1959
ALCOHOLISM. The British journal of clinical practice, 1964, Volume: 18 Topics: Alcohol Deterrents; Alcoholism; Apomorphine; Chlorpromazine; Diet; Diet Therapy; Disulfiram; Humans; Promazine; Psychoses, Alcoholic; Psychotic Disorders; Vitamin A; Vitamin K; Vitamins	1964
[Treatment of manic-depressive psychoses with apomorphine]. Lekarske listy, 1950, Dec-01, Volume: 5, Issue:23 Topics: Apomorphine; Bipolar Disorder; Humans; Mental Disorders; Morphine; Psychotic Disorders	1950
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis. Psychopharmacology, 2005, Volume: 180, Issue:3 Topics: Amphetamine; Amphetamines; Animals; Apomorphine; Behavior, Animal; Cues; Discrimination Learning; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluorobenzenes; Hallucinogens; Haloperidol; Indans; Injections, Intraperitoneal; Lysergic Acid Diethylamide; Male; Piperidines; Psychotic Disorders; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors	2005
Two distinctive apomorphine-induced phenotypes in the Roman high- and low-avoidance rats. Physiology & behavior, 2005, Nov-15, Volume: 86, Issue:4 Topics: Animals; Apomorphine; Behavior, Animal; Breeding; Dopamine; Dopamine Agonists; Genetic Predisposition to Disease; Male; Motor Activity; Phenotype; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Species Specificity; Stereotyped Behavior; Yawning	2005
Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:11 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Callithrix; Disability Evaluation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Grooming; Hallucinations; Levodopa; Parkinsonian Disorders; Psychomotor Agitation; Psychotic Disorders; Statistics, Nonparametric; Stereotyped Behavior	2006
Mood-incongruent versus mood-congruent psychosis: differential antipsychotic response to lithium therapy. Psychiatry research, 1984, Volume: 11, Issue:4 Topics: Apomorphine; Bipolar Disorder; Growth Hormone; Humans; Lithium; Psychotic Disorders; Schizophrenia; Time Factors	1984
The prolactin response in schizophrenic, schizophreniform, and manic disorders. Biological psychiatry, 1984, Volume: 19, Issue:6 Topics: Apomorphine; Bipolar Disorder; Female; Humans; Male; Prolactin; Psychotic Disorders; Schizophrenia	1984
Dopamine supersensitivity and hormonal status in puerperal psychosis. The British journal of psychiatry : the journal of mental science, 1995, Volume: 166, Issue:1 Topics: Adult; Apomorphine; Biomarkers; Estradiol; Female; Growth Hormone; Humans; Hypothalamus; Male; Pilot Projects; Pregnancy; Progesterone; Prolactin; Psychotic Disorders; Puerperal Disorders; Receptors, Dopamine; Reference Values; Risk Factors; Thyroid Hormones	1995
Neuroendocrine and psychosocial mechanisms in post-partum psychosis. Progress in neuro-psychopharmacology & biological psychiatry, 1993, Volume: 17, Issue:4 Topics: Adult; Apomorphine; Bipolar Disorder; Depressive Disorder; Female; Growth Hormone; Humans; Life Change Events; Neurosecretory Systems; Pregnancy; Psychotic Disorders; Puerperal Disorders; Recurrence; Risk Factors; Stress, Psychological	1993
Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia. Prevalence and clinical correlates. Archives of general psychiatry, 1993, Volume: 50, Issue:5 Topics: Adolescent; Adult; Apomorphine; Biomarkers; Brain; Cohort Studies; Dopamine; Eye Movements; Female; Growth Hormone; Humans; Magnetic Resonance Imaging; Male; Methylphenidate; Prospective Studies; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index	1993
N30 wave amplitude of somatosensory evoked potentials from median nerve in Parkinson's disease: a pharmacological study. Journal of neural transmission. Supplementum, 1995, Volume: 45 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Basal Ganglia Diseases; Case-Control Studies; Dopamine Agonists; Evoked Potentials, Somatosensory; Humans; Levodopa; Median Nerve; Middle Aged; Parkinson Disease; Psychotic Disorders; Reaction Time; Reference Values	1995
Involvement of GABAergic neurotransmission in the neurobiology of the apomorphine-induced aggressive behavior paradigm, a model of psychotic behavior in rats. Methods and findings in experimental and clinical pharmacology, 2000, Volume: 22, Issue:8 Topics: Aggression; Animals; Apomorphine; Baclofen; Behavior, Animal; Disease Models, Animal; GABA Agonists; Isoxazoles; Male; Neurotransmitter Agents; Psychotic Disorders; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, GABA-B; Synaptic Transmission	2000
Preliminary phytochemical, pharmacological and antibacterial studies of the alkaloidal extracts of the leaves of Synclisia scabrida Miers. Journal of ethnopharmacology, 1986, Volume: 18, Issue:2 Topics: Alkaloids; Animals; Apomorphine; Behavior, Animal; Catalepsy; Chickens; Chromatography, Thin Layer; Electroencephalography; Electromyography; Female; Male; Plant Extracts; Plants, Medicinal; Pseudomonas aeruginosa; Psychotic Disorders; Rats; Rats, Inbred Strains; Staphylococcus aureus	1986
Growth hormone response to apomorphine and family patterns of illness. Biological psychiatry, 1987, Volume: 22, Issue:6 Topics: Adolescent; Adult; Aged; Antisocial Personality Disorder; Apomorphine; Genetic Markers; Growth Hormone; Humans; Middle Aged; Pituitary Gland, Anterior; Psychotic Disorders; Schizophrenia; Schizotypal Personality Disorder	1987
Growth hormone response to apomorphine and diagnosis: a comparison of three diagnostic systems. Biological psychiatry, 1986, Volume: 21, Issue:5-6 Topics: Adult; Apomorphine; Bipolar Disorder; Female; Growth Hormone; Humans; Male; Middle Aged; Mood Disorders; Psychotic Disorders; Schizophrenia	1986
Relation of clinical symptoms to apomorphine-stimulated growth hormone release in mood-incongruent psychotic patients. Archives of general psychiatry, 1986, Volume: 43, Issue:12 Topics: Adolescent; Adult; Age Factors; Apomorphine; Dopamine; Female; Growth Hormone; Hospitalization; Humans; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology	1986
Growth hormone response to apomorphine. Archives of general psychiatry, 1987, Volume: 44, Issue:1 Topics: Apomorphine; Diagnosis, Differential; Female; Growth Hormone; Humans; Male; Psychotic Disorders; Schizophrenia	1987
Apomorphine has no effect on plasma homovanillic acid in schizophrenic patients. Psychiatry research, 1985, Volume: 16, Issue:2 Topics: Adult; Apomorphine; Haloperidol; Homovanillic Acid; Humans; Male; Middle Aged; Psychotic Disorders; Schizophrenia	1985
Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine. Arzneimittel-Forschung, 1968, Volume: 18, Issue:3 Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Benzimidazoles; Blepharoptosis; Body Temperature Regulation; Cardiovascular System; Catalepsy; Cats; Chlorpromazine; Delayed-Action Preparations; Dogs; Female; Guinea Pigs; Haloperidol; Haplorhini; Histamine H1 Antagonists; Humans; In Vitro Techniques; Male; Methods; Mice; Muscle Contraction; Norepinephrine; Psychotic Disorders; Rabbits; Rats; Swine; Tranquilizing Agents; Vasoconstrictor Agents	1968
[Sulpiride in pediatrics]. Fortschritte der Medizin, 1973, Apr-19, Volume: 91, Issue:11 Topics: Adolescent; Apomorphine; Benzamides; Chemical Phenomena; Chemistry; Child; Child Behavior Disorders; Child, Preschool; Humans; Infant; Infant, Newborn; Nervous System Diseases; Neurotic Disorders; Peptic Ulcer; Psychotic Disorders; Pyrrolidines; Sleep Wake Disorders; Tranquilizing Agents	1973
Definition and classification of neuroleptics. Modern problems of pharmacopsychiatry, 1970, Volume: 5 Topics: Amphetamine; Animals; Apomorphine; Autonomic Nervous System; Basal Ganglia Diseases; Behavior; Catalepsy; Chemical Phenomena; Chemistry; Humans; Hypnotics and Sedatives; Motor Activity; Parkinson Disease, Secondary; Psychotic Disorders; Structure-Activity Relationship; Tranquilizing Agents	1970
The neuroleptics. 3. Pharmacology. Introduction. Modern problems of pharmacopsychiatry, 1970, Volume: 5 Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior; Behavior, Animal; Blepharoptosis; Brain; Catalepsy; Chemical Phenomena; Chemistry; Conditioning, Psychological; Disease Models, Animal; Dopamine Antagonists; Humans; Psychotic Disorders; Self Stimulation; Tranquilizing Agents	1970
Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction. Modern problems of pharmacopsychiatry, 1970, Volume: 5 Topics: Amphetamine; Animals; Apomorphine; Behavior; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine Antagonists; Drug Interactions; Humans; Psychotic Disorders; Rats; Reserpine; Time Factors; Tranquilizing Agents	1970